Sigilon Therapeutics, Inc.
SGTXDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821323
Sigilon Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 15, 2023; 16 institutions reported holding it in 13F filings for Q2 2023, worth $26.6M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Sigilon Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 37 | 33 | −4 |
| Shares | 17.1M | 16.9M | −137.3K (−0.8%) |
| Value | $14.2M | $8.50M | −$5.67M (−40.0%) |
New holders (2)
Institutions that held Sigilon Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Man Group plc | 15,240 | $8.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 12 | $0 | 0.00% |
Sold out (6)
Institutions that held Sigilon Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 46,845 | $39.0K |
| Legal & General Group Plc | 1,231 | $1.00K |
| Captrust Financial Advisors | 1,500 | $1.00K |
| New York State Common Retirement Fund | 143 | $0 |
| Credit Suisse AG | 8 | $0 |
| Citigroup Inc | 451 | $0 |